Latanoprostene bunod ophthalmic Alternatives Compared
| Latanoprostene bunod ophthalmic | Combigan (brimonidine / timolol) | Zioptan (tafluprost) |
|
|---|
| Latanoprostene bunod ophthalmic | Combigan (brimonidine / timolol) | Zioptan (tafluprost) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glaucoma - Open Angle, Glaucoma/Intraocular Hypertension. Latanoprostene bunod ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma, Glaucoma/Intraocular Hypertension, Intraocular Hypertension. Combigan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma - Open Angle, Glaucoma/Intraocular Hypertension, Intraocular Hypertension. Zioptan may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma/Intraocular Hypertension
|
|||||||||||||||
| More about Latanoprostene bunod ophthalmic | More about Combigan (brimonidine / timolol) | More about Zioptan (tafluprost) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Latanoprostene bunod ophthalmic has an average rating of 7.0 out of 10 from a total of 15 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 27% reported a negative effect. |
Combigan has an average rating of 4.9 out of 10 from a total of 25 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 48% reported a negative effect. |
Zioptan has an average rating of 5.9 out of 10 from a total of 14 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Combigan side effects |
View all Zioptan side effects |
|||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Combigan prices |
View all Zioptan prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Vyzulta |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
7 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 7 drugs are known to interact with Latanoprostene bunod ophthalmic:
|
A total of 550 drugs are known to interact with Combigan:
|
A total of 6 drugs are known to interact with Zioptan:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
October 30, 2007 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.